observatornews.ro/eveniment/bolnavii-din-romania-a
In Romania, patients wait nearly three years for access to new medications, significantly impacting their health outcomes. This delay is particularly critical for cancer patients, where timely treatment can be life-saving. Only 28 out of 168 new drugs approved in the EU from 2021 to 2024 are available in Romania, leading to a longer wait time than the European average. Medical professionals and pharmaceutical companies are advocating for better collaboration, including the establishment of a National Council for Life Sciences to address these issues. The aim is to improve access to innovative treatments and enhance the overall healthcare system, ultimately benefiting patients and society.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.